Arbutus Biopharma Corp Quarterly Operating Income (Loss) in USD from Q1 2013 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Arbutus Biopharma Corp quarterly/annual Operating Income (Loss) history and growth rate from Q1 2013 to Q3 2024.
  • Arbutus Biopharma Corp Operating Income (Loss) for the quarter ending September 30, 2024 was -$21.4M, a 0.55% increase year-over-year.
  • Arbutus Biopharma Corp Operating Income (Loss) for the twelve months ending September 30, 2024 was -$83.1M, a 4.02% decline year-over-year.
  • Arbutus Biopharma Corp annual Operating Income (Loss) for 2023 was -$78.1M, a 19.3% decline from 2022.
  • Arbutus Biopharma Corp annual Operating Income (Loss) for 2022 was -$65.5M, a 11% increase from 2021.
  • Arbutus Biopharma Corp annual Operating Income (Loss) for 2021 was -$73.5M, a 27.2% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$83.1M -$21.4M +$118K +0.55% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 -$83.3M -$21.6M -$3.2M -17.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$80.1M -$19.4M -$1.95M -11.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 -$78.1M -$20.7M +$1.82M +8.04% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-05
Q3 2023 -$79.9M -$21.6M -$3.75M -21% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 -$76.2M -$18.4M -$4.28M -30.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$71.9M -$17.4M -$6.44M -58.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 -$65.5M -$22.6M -$1.77M -8.49% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-05
Q3 2022 -$63.7M -$17.8M +$597K +3.24% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 -$64.3M -$14.1M +$4.53M +24.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 -$68.8M -$11M +$4.7M +30% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 -$73.5M -$20.8M -$4.5M -27.6% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-02
Q3 2021 -$69M -$18.4M -$3.19M -21% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$65.8M -$18.6M -$5.5M -41.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 -$60.3M -$15.7M -$2.53M -19.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 -$57.8M -$16.3M -$3.21M -24.6% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-03
Q3 2020 -$54.6M -$15.2M +$75.8M +83.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$130M -$13.1M +$7.5M +36.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$138M -$13.1M +$6.05M +31.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 -$144M -$13.1M +$3.82M +22.6% Oct 1, 2019 Dec 31, 2019 10-K 2020-03-05
Q3 2019 -$148M -$91M -$58.6M -181% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 -$89.2M -$20.6M +$1.4M +6.36% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-07
Q1 2019 -$90.6M -$19.2M -$791K -4.3% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 -$89.8M -$16.9M +$43.3M +71.9% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-05
Q3 2018 -$133M -$32.4M -$19.5M -151% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 -$114M -$22M -$2.56M -13.1% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-05
Q1 2018 -$111M -$18.4M -$106K -0.58% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-05
Q4 2017 -$111M -$60.2M +$197M +76.6% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-07
Q3 2017 -$308M -$12.9M +$6.08M +32% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-07
Q2 2017 -$314M -$19.5M +$176M +90% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-07
Q1 2017 -$490M -$18.3M +$1.68M +8.4% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-07
Q4 2016 -$492M -$257M -$246M -2089% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-16
Q3 2016 -$246M -$19M +$39.2M +67.4% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-16
Q2 2016 -$285M -$195M -$181M -1254% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-16
Q1 2016 -$104M -$20M -$1.97M -10.9% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-16
Q4 2015 -$102M -$11.8M -$1.01M -9.41% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-22
Q3 2015 -$101M -$58.1M -$51.3M -749% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-22
Q2 2015 -$50M -$14.4M -$5M -53% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-22
Q1 2015 -$45M -$18M -$12M -202% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-22
Q4 2014 -$33M -$10.7M -$8.31M -341% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-09
Q3 2014 -$24.7M -$6.84M -$3.19M -87.4% Jul 1, 2014 Sep 30, 2014 10-K 2016-03-09
Q2 2014 -$21.5M -$9.42M -$6.35M -207% Apr 1, 2014 Jun 30, 2014 10-K 2016-03-09
Q1 2014 -$15.1M -$5.96M -$2.96M -99% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-09
Q4 2013 -$12.2M -$2.44M Oct 1, 2013 Dec 31, 2013 10-K 2015-03-13
Q3 2013 -$3.65M Jul 1, 2013 Sep 30, 2013 10-K 2015-03-13
Q2 2013 -$3.07M Apr 1, 2013 Jun 30, 2013 10-K 2015-03-13
Q1 2013 -$2.99M Jan 1, 2013 Mar 31, 2013 10-K 2015-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.